{"id":"NCT01044030","sponsor":"Boston Children's Hospital","briefTitle":"Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children","officialTitle":"Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2012-06","completion":"2012-06","firstPosted":"2010-01-07","resultsPosted":"2015-03-20","lastUpdate":"2018-06-20"},"enrollment":326,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Acute Otitis Media"],"interventions":[{"type":"DRUG","name":"Xylitol syrup","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Xylitol syrup","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of the proposed study is to determine the effectiveness and safety of orally administered viscous-adherent xylitol syrup given in a dose of five grams three times daily for 12 weeks in reducing the incidence of clinically-diagnosed acute otitis media (ear infection) in children with a history of recurrent acute otitis media.","primaryOutcome":{"measure":"Effectiveness of Viscous-adherent Xylitol Syrup in Reducing Episodes of Clinically-diagnosed Acute Otitis Media","timeFrame":"12 weeks","effectByArm":[{"arm":"Xylitol Syrup","deltaMin":66.9,"sd":null},{"arm":"Placebo","deltaMin":63.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6"}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["17097152","24394686"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":160},"commonTop":["Diarrhea","Upper respiratory tract infection","Flatulence","Abdominal Pain"]}}